{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:23:07Z","timestamp":1793035387806,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL150562"],"award-info":[{"award-number":["1R01HL150562"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-04009-3","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T19:10:21Z","timestamp":1731438621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cell-based therapies reverse the heart failure-altered right ventricular proteome towards a pre-disease state"],"prefix":"10.1186","volume":"15","author":[{"given":"Nour","family":"Makkaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhya","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia L.","family":"Latham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina M.","family":"Furdui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7389-5245","authenticated-orcid":false,"given":"Joshua T.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"23","key":"4009_CR1","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1161\/CIRCULATIONAHA.106.183216","volume":"115","author":"KJ Jenkins","year":"2007","unstructured":"Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115(23):2995\u20133014.","journal-title":"Circulation"},{"issue":"10","key":"4009_CR2","first-page":"1","volume":"8","author":"J Guihaire","year":"2012","unstructured":"Guihaire J, Haddad F, Mercier O, Murphy DJ, Wu JC, Fadel E. The right heart in congenital heart disease, mechanisms and recent advances. J Clini Exp Cardiol. 2012;8(10):1\u201311.","journal-title":"J Clini Exp Cardiol"},{"issue":"12","key":"4009_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/hrt.2008.156265","volume":"95","author":"MM Winter","year":"2009","unstructured":"Winter MM, Bouma BJ, Groenink M, Konings TC, Tijssen JGP, van Veldhuisen DJ, et al. Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure. Heart. 2009;95(12):960\u20133.","journal-title":"Heart"},{"issue":"17","key":"4009_CR4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","volume":"114","author":"NF Voelkel","year":"2006","unstructured":"Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883\u201391.","journal-title":"Circulation"},{"key":"4009_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ahj.2017.06.009","volume":"192","author":"S Kaushal","year":"2017","unstructured":"Kaushal S, Wehman B, Pietris N, Naughton C, Bentzen SM, Bigham G, et al. Study design and rationale for ELPIS: a phase I\/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. Am Heart J. 2017;192:48\u201356.","journal-title":"Am Heart J"},{"issue":"10","key":"4009_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3727\/000000005783982558","volume":"14","author":"S Zhang","year":"2005","unstructured":"Zhang S, Jia Z, Ge J, Gong L, Ma Y, Li T, et al. Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats. Cell Transpl. 2005;14(10):787\u201398.","journal-title":"Cell Transpl"},{"issue":"4","key":"4009_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.116.304671","volume":"116","author":"S Ishigami","year":"2015","unstructured":"Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, et al. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2015;116(4):653\u201364.","journal-title":"Circ Res"},{"issue":"7","key":"4009_CR8","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/CIRCRESAHA.116.310253","volume":"120","author":"S Ishigami","year":"2017","unstructured":"Ishigami S, Ohtsuki S, Eitoku T, Ousaka D, Kondo M, Kurita Y, et al. Intracoronary cardiac progenitor cells in single ventricle physiology: the PERSEUS (cardiac progenitor cell infusion to treat univentricular heart disease) randomized phase 2 trial. Circ Res. 2017;120(7):1162\u201373.","journal-title":"Circ Res"},{"issue":"5","key":"4009_CR9","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jtcvs.2015.06.076","volume":"150","author":"S Tarui","year":"2015","unstructured":"Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, et al. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: Three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thorac Cardiovasc Surg. 2015;150(5):1198\u2013207.","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"7","key":"4009_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1161\/CIRCRESAHA.117.312311","volume":"122","author":"T Sano","year":"2018","unstructured":"Sano T, Ousaka D, Goto T, Ishigami S, Hirai K, Kasahara S, et al. Impact of cardiac progenitor cells on heart failure and survival in single ventricle congenital heart disease. Circ Res. 2018;122(7):994\u20131005.","journal-title":"Circ Res"},{"issue":"8","key":"4009_CR11","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1002\/clc.20463","volume":"33","author":"A Limsuwan","year":"2010","unstructured":"Limsuwan A, Pienvichit P, Limpijankit T, Khowsathit P, Hongeng S, Pornkul R, et al. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience. Clin Cardiol. 2010;33(8):E7-12.","journal-title":"Clin Cardiol"},{"issue":"8","key":"4009_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.healun.2017.01.008","volume":"36","author":"ES Pincott","year":"2017","unstructured":"Pincott ES, Ridout D, Brocklesby M, McEwan A, Muthurangu V, Burch M. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy. J Heart Lung Transplant. 2017;36(8):837\u201344.","journal-title":"J Heart Lung Transplant"},{"issue":"7\u20138","key":"4009_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3727\/000000004783983477","volume":"13","author":"RJ Henning","year":"2004","unstructured":"Henning RJ, Abu-Ali H, Balis JU, Morgan MB, Willing AE, Sanberg PR. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004;13(7\u20138):729\u201339.","journal-title":"Cell Transplant"},{"issue":"2","key":"4009_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5966\/sctm.2014-0195","volume":"4","author":"S Cantero Peral","year":"2015","unstructured":"Cantero Peral S, Burkhart HM, Oommen S, Yamada S, Nyberg SL, Li X, et al. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Transl Med. 2015;4(2):195\u2013206.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"4009_CR15","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jtcvs.2019.06.001","volume":"158","author":"HM Burkhart","year":"2019","unstructured":"Burkhart HM, Qureshi MY, Rossano JW, Cantero Peral S, O\u2019Leary PW, Hathcock M, et al. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections. J Thorac Cardiovasc Surg. 2019;158(6):1614\u201323.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"4009_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.116.304671","volume":"116","author":"S Ishigami","year":"2015","unstructured":"Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, et al. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial. Circ Res. 2015;116(4):653\u201364.","journal-title":"Circ Res"},{"issue":"5","key":"4009_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jtcvs.2015.06.076","volume":"150","author":"S Tarui","year":"2021","unstructured":"Tarui S, Ishigami S, Ousaka D, Kasahara S, Ohtsuki S, Sano S, et al. Transcoronary infusion of cardiac progenitor cells in hypoplastic left heart syndrome: three-year follow-up of the Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single-Ventricle Physiology (TICAP) trial. J Thoracic Cardiovas Surg. 2021;150(5):1198\u20132082.","journal-title":"J Thoracic Cardiovas Surg."},{"issue":"7","key":"4009_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00246-022-02872-6","volume":"43","author":"S Kaushal","year":"2022","unstructured":"Kaushal S, Hare JM, Shah AM, Pietris NP, Bettencourt JL, Piller LB, et al. Autologous cardiac stem cell injection in patients with hypoplastic left heart syndrome (CHILD study). Pediatr Cardiol. 2022;43(7):1481\u201393.","journal-title":"Pediatr Cardiol"},{"issue":"7","key":"4009_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/eurjhf\/hfq063","volume":"12","author":"H Maxeiner","year":"2010","unstructured":"Maxeiner H, Krehbiehl N, Muller A, Woitasky N, Akinturk H, Muller M, et al. New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail. 2010;12(7):730\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"4009_CR20","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1089\/scd.2012.0602","volume":"22","author":"ST Hsiao","year":"2013","unstructured":"Hsiao ST, Lokmic Z, Peshavariya H, Abberton KM, Dusting GJ, Lim SY, et al. Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells. Stem Cells Dev. 2013;22(10):1614\u201323.","journal-title":"Stem Cells Dev"},{"key":"4009_CR21","doi-asserted-by":"crossref","unstructured":"Mayourian J, Ceholski DK, Gorski P, Mathiyalagan P, Murphy JF, Salazar SI, et al. Exosomal microRNA-21\u20135p mediates mesenchymal stem cell paracrine effects on human cardiac tissue contractility. Circ Res. 2018.","DOI":"10.1161\/CIRCRESAHA.118.312420"},{"issue":"4","key":"4009_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/CIRCRESAHA.116.309935","volume":"120","author":"U Agarwal","year":"2017","unstructured":"Agarwal U, George A, Bhutani S, Ghosh-Choudhary S, Maxwell JT, Brown ME, et al. Experimental, systems, and computational approaches to understanding the microRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients. Circ Res. 2017;120(4):701\u201312.","journal-title":"Circ Res"},{"issue":"2","key":"4009_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","volume":"116","author":"WD Gray","year":"2015","unstructured":"Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res. 2015;116(2):255\u201363.","journal-title":"Circ Res"},{"issue":"2","key":"4009_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.08.005","volume":"50","author":"M Mirotsou","year":"2011","unstructured":"Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011;50(2):280\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"4009_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5966\/sctm.2015-0241","volume":"5","author":"U Agarwal","year":"2016","unstructured":"Agarwal U, Smith AW, French KM, Boopathy AV, George A, Trac D, et al. Age-dependent effect of pediatric cardiac progenitor cells after juvenile heart failure. Stem Cells Transl Med. 2016;5(7):883\u201392.","journal-title":"Stem Cells Transl Med"},{"issue":"12","key":"4009_CR26","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/stem.3088","volume":"37","author":"JT Maxwell","year":"2019","unstructured":"Maxwell JT, Trac D, Shen M, Brown ME, Davis ME, Chao MS, et al. Electrical Stimulation of pediatric cardiac-derived c-kit(+) progenitor cells improves retention and cardiac function in right ventricular heart failure. Stem Cells (Dayton, Ohio). 2019;37(12):1528\u201341.","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"4009_CR27","doi-asserted-by":"crossref","unstructured":"Trac D, Maxwell JT, Brown ME, Xu C, Davis ME. Aggregation of child cardiac progenitor cells into spheres activates notch signaling and improves treatment of right ventricular heart failure. Circ Res. 2018.","DOI":"10.1161\/res.123.suppl_1.345"},{"issue":"1","key":"4009_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","volume":"4","author":"NT Seyfried","year":"2017","unstructured":"Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, et al. A Multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer\u2019s disease. Cell Syst. 2017;4(1):60\u2013724.","journal-title":"Cell Syst."},{"issue":"1","key":"4009_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13287-015-0044-y","volume":"6","author":"S Oommen","year":"2015","unstructured":"Oommen S, Yamada S, Cantero Peral S, Campbell KA, Bruinsma ES, Terzic A, et al. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res Ther. 2015;6(1):50.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4009_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0008-6363(95)00121-2","volume":"31","author":"AJ de Bold","year":"1996","unstructured":"de Bold AJ, Bruneau BG, de Kuroski BML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res. 1996;31(1):7\u201318.","journal-title":"Cardiovasc Res."},{"issue":"4","key":"4009_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0735-1097(01)01509-1","volume":"38","author":"DS Lim","year":"2001","unstructured":"Lim DS, Roberts R, Marian AJ. Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. J Am Coll Cardiol. 2001;38(4):1175\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4009_CR32","doi-asserted-by":"publisher","first-page":"2000017","DOI":"10.1002\/prca.202000017","volume":"14","author":"RC Parreira","year":"2020","unstructured":"Parreira RC, G\u00f3mez-Mendoza DP, de Jesus ICG, Lemos RP, Santos AK, Rezende CP, et al. Cardiomyocyte proteome remodeling due to isoproterenol-induced cardiac hypertrophy during the compensated phase. Proteom Clini Appl. 2020;14(4):2000017.","journal-title":"Proteom Clini Appl."},{"issue":"4","key":"4009_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jtcvs.2008.09.006","volume":"137","author":"E Bovill","year":"2009","unstructured":"Bovill E, Westaby S, Crisp A, Jacobs S, Shaw T. Reduction of four-and-a-half LIM-protein 2 expression occurs in human left ventricular failure and leads to altered localization and reduced activity of metabolic enzymes. J Thorac Cardiovasc Surg. 2009;137(4):853\u201361.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"4009_CR34","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41536-020-0091-6","volume":"5","author":"DK Arrell","year":"2020","unstructured":"Arrell DK, Rosenow CS, Yamada S, Behfar A, Terzic A. Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome. NPJ Regen Med. 2020;5(1):552.","journal-title":"NPJ Regen Med."},{"issue":"9","key":"4009_CR35","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/sctm.20-0509","volume":"10","author":"DK Arrell","year":"2021","unstructured":"Arrell DK, Crespo-Diaz RJ, Yamada S, Jeon R, Garmany A, Park S, et al. Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome. Stem Cells Transl Med. 2021;10(9):1320\u20138.","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"4009_CR36","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","volume":"121","author":"V Florea","year":"2017","unstructured":"Florea V, Rieger AC, DiFede DL, El-Khorazaty J, Natsumeda M, Banerjee MN, et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res. 2017;121(11):1279\u201390.","journal-title":"Circ Res"},{"issue":"2","key":"4009_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5966\/sctm.2015-0101","volume":"5","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, et al. Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease. Stem Cells Transl Med. 2016;5(2):186\u201391.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"4009_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","volume":"117","author":"EC Perin","year":"2015","unstructured":"Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, et al. A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure. Circ Res. 2015;117(6):576\u201384.","journal-title":"Circ Res"},{"issue":"4","key":"4009_CR39","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCINTERVENTIONS.114.001436","volume":"7","author":"G Poglajen","year":"2014","unstructured":"Poglajen G, Sever M, Cukjati M, Cernelc P, Knezevic I, Zemljic G, et al. Effects of transendocardial CD34+ cell transplantation in patients with ischemic cardiomyopathy. Circ Cardiovasc Interv. 2014;7(4):552\u20139.","journal-title":"Circ Cardiovasc Interv"},{"issue":"22","key":"4009_CR40","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, et al. Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012;308(22):2369\u201379.","journal-title":"JAMA"},{"issue":"1","key":"4009_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ahj.2010.09.025","volume":"161","author":"AA Quyyumi","year":"2011","unstructured":"Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, et al. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011;161(1):98\u2013105.","journal-title":"Am Heart J"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-04009-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-04009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T20:04:13Z","timestamp":1731441853000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-04009-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4009"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-04009-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4752035\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at Children\u2019s Healthcare of Atlanta and Emory University for the isolation of human c-kit positive cells from patients (Protocol title: Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development; Protocol number: IRB00005500; approved on 08\/15\/2017). The patients or their guardians\/legally authorized representatives provided written informed consent for participation in the study and the use of samples. All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee of Emory University (Protocol title: Development of novel therapies for right heart failure; Protocol number: DAR-4000044-ENTRPR-N; approved on 09\/12\/2017) and conform to the guidelines from the NIH Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"420"}}